First, heavy! Shanghai merger and reorganization action plan announcedIn addition, it is planned to distribute a cash dividend of 12.3 yuan to all shareholders for every 10 shares, with a total dividend of 4.5 billion yuan. In April this year, Ningde has paid dividends of 22 billion yuan, and this time it totaled 27.4 billion yuan. According to the current market value of 11,900, the corresponding dividend yield is 2.3%! It's really not low.Wentai Technology: Shareholders plan to reduce their holdings by no more than 2%;
Xinhua News Agency: China's monetary policy has changed from "prudent" to "moderately loose" to send a positive signal.Guoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;Contemporary Amperex Technology Co., Limited, as the king of volume, stopped making money everywhere and began to repay investors! Other domestic new energy giants can learn from it. Yesterday, Ning Wang opened higher and lower, and took the GEM with a bias. In the evening, the two big benefits were blessed. Can today's surge drive the GEM to rise?
Let's talk about some encouraging and unintelligent observations. Now the main purpose of everyone's smashing is to adjust positions, not to sell them back. This is the biggest difference from the past few years! Explain that regardless of retail investors, institutions and foreign investors, they still believe in the A-share bull market.Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.After the market closed, the Shanghai Municipal Government issued the Action Plan for Shanghai to Support the Merger and Reorganization of Listed Companies (2025-2027). Among them, it is proposed to strive to land a number of representative M&A cases in key industries by 2027, and cultivate about 10 internationally competitive listed companies in key industries such as integrated circuits, biomedicine and new materials, forming a scale of M&A transactions of 300 billion yuan and activating total assets of over 2 trillion yuan. In addition, the plan also mentioned that the merger of securities companies should be accelerated to build a first-class investment bank.
Strategy guide
12-14
Strategy guide
Strategy guide
12-14
Strategy guide 12-14